AcelRx Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ACRX and buy or sell other stocks, ETFs, and their options commission-free!About ACRX
Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03.
CEOVincent J. Angotti, MBA
CEOVincent J. Angotti, MBA
Employees13
Employees13
HeadquartersSan Mateo, California
HeadquartersSan Mateo, California
Founded2005
Founded2005
Employees13
Employees13
ACRX Key Statistics
Market cap39.20M
Market cap39.20M
Price-Earnings ratio-2.78
Price-Earnings ratio-2.78
Dividend yield—
Dividend yield—
Average volume296.72K
Average volume296.72K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.45
52 Week high$1.45
52 Week low$0.38
52 Week low$0.38
Stock Snapshot
The current AcelRx Pharmaceuticals(ACRX) stock price is $0.86, with a market capitalization of 39.2M. The stock trades at a price-to-earnings (P/E) ratio of -2.78.
During the trading day, AcelRx Pharmaceuticals(ACRX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for AcelRx Pharmaceuticals(ACRX) stock has reached 0, versus its average volume of 296.72K.
The stock's 52-week range extends from a low of $0.38 to a high of $1.45.
The stock's 52-week range extends from a low of $0.38 to a high of $1.45.
People also own
Based on the portfolios of people who own ACRX. This list is generated using Robinhood data, and it’s not a recommendation.